ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
BGC0000446.1|Tilivalline_1 # 3 # 83 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.506	BGC0000446.1|Tilivalline_1 	3	83	+	Loose	2070	20.0162	smeE	31.58	3003056	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; tetracycline antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	TCCTCTGACTGGACTCGAACCAGTGACATACGGATTAACAGTCCGCCGTTCTACCGACTGAACTACAGAGGAATCGTGTGA	SSDWTRTSDIRINSPPFYRLNYRGIV	MARFFIDRPIFAWVIAIIIMLAGGLALFKLPVSMYPNVAPPAVEISATYPGASAKVVEDSVTQIIEQNMKGLDGLIYFSSNSSSNGQATITLTFESGTNPDIAQVQVQNKLQLAMPLLPQEVQRQGINVAKSSSGFLNAIAFVSENGSMDANDIADYVGSNVVDRLSRVPGVGNIQVFGGKYAMRIWLDPNKLHTYGLSVPEVTAAIKAQNAQVAIGQLGGAPSVKGQQLNATINAQSRLQTPEQFRNIIVRGAQDGAELRLGDVARVELGAESYDFVTRYNGQPASGLAVTLATGANALDTAAGVDAALEDMKGFFPAGLKAEIPYDTTPFVRVSIKGVVQTLIEAIVLVFVVMYLFLQNFRATLIPTIAVPVVLLGTFGVLAMLGFSVNMLTMFAMVLAIGLLVDDAIVVVENVERIMSEEGLSPLEATRKSMGQITGALVGIGLVLSAVFVPMAFMSGSTGVIYRQFSATIVSAMALSVLVAIVLTPALCATMLKPLKKGEHHVAHRGLAGRFFNGFNRGFDRTSESYQRGVRGIIHRPWRFMGIVAALFVLMGVLFVRLPSSFLPNEDQGVLMALVQAPVGATQERTLESIAALENHFLQNEKDAVDSVFSVQGFSFAGMGQNAGMAFVKLKDWSERDADNGVMPITGRAMAALGQIKDAFIFAFPPPAIPELGTASGYTFFLKDNSGQGHEALVAARNQLLGLAAGSKKLANVRPNGQEDTPQFRIDIDAAKATSLGLSIDQINGTLAAAWGSSYIDDFVDRGRVKRVFVQADQAFRMVPEDFDLWSVKNDKGEMVPFSAFATKHWDYGSPRLERYNGVSAMEIQGEPAPGVASGDAMAEIEQLAKQLPAGFGIEWTAMSYQERQAGSQTPLLYTLSLMIVFLCLAAMYESWSVPTAVLLAAPLGILGAVLANTFKGLERDIYFQVAMLTTVGLTSKNAILIVEFAKENLEKGASLIESIMHAVRDRLRPIVMTSLAFGMGVVPLAISTGAGSGAKQAIGTGVLGGMIVGTVLGVFFVPLFFVVVQRVFKRRSTT	2.50	gnl|BL_ORD_ID|825|hsp_num:0	876		
BGC0000446.1|Tilivalline_2 # 375 # 1322 # 1 # ID=1_2;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.584	BGC0000446.1|Tilivalline_2 	375	1322	+	Loose	550	37.3502	NmcR	44.44	3003665	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam	antibiotic inactivation	NmcA beta-lactamase	TTGGTACTGGTGTTCCTTACAGGAGGCAAAATGAACTTAAGACGACTGAAGTATTTCGTAAAAATCGTCGATATCGGCAGTCTGACCCAGGCCGCTGAAGTCTTGCACATCGCACAACCGGCGCTGAGCCAGCAGGTTGCGACCCTGGAAGGCGAGCTGGACCAGCAGTTGTTGATTCGCACCAAACGCGGCGTCACGCCGACCGAAGCGGGCAAGATCTTGTATACCCACGCCCGTACTATTCTGCGCCAGTGCGAGCAGGCGCAGCTGGCGGTAAATAATGTCGGTCAAACGCTAAGTGGCCAGGTATCGATTGGCCTGGCGCCTGGCACGGCGGCTTCGGCCATCACTATGCCGCTGCTGCAAACGGTGCGTAACGAGCTGCCGGAAGTGATGGTCTATCTCCAGGAAAGTAGCGGAACCCTCCTCAACGATAAGCTTATCGACGGTCAGCTGGATATGGCCGTACTTTATGAACGTTCCCCGGTTGCCGGGATCATCAGCCAGCCGCTGCTAAAAGAAGATCTCTACCTGGTCGGTACCCGGGATTGTCCGGGGCAGAGCGTGGATCTGACGGCGGTCGCGGAGATGAATCTGTTCTTGCCGCGCGATTACAGCGCCGTTCGCGCAAGGGTGACCGAAGCCTTCACCCTGCGTCGCTTATCGGCCAAAATTATCGGTGAAATTGAATCCATTACCACCCTGACGGCAGCCATTGCCAGCGGCATGGGCGTCACCGTTCTGCCGGAGTCCGCCGCCCGTTCGTTGTGCAGCGCGGCCAACGGCTGGATGGCGCGCATCAGCACGCCGTCAATGAGCCTGTCGCTGTCGCTCAATATGTCGGCTCGCGGCAGTCTGTCGCCGCAGGCGCAGGCGGTGAAGGAGATCCTGATGTCGCTGGTGAGTCGCCCGTCGCTGGAGAATCGTGAATTACAGTTAGTCAGTTGA	MVLVFLTGGKMNLRRLKYFVKIVDIGSLTQAAEVLHIAQPALSQQVATLEGELDQQLLIRTKRGVTPTEAGKILYTHARTILRQCEQAQLAVNNVGQTLSGQVSIGLAPGTAASAITMPLLQTVRNELPEVMVYLQESSGTLLNDKLIDGQLDMAVLYERSPVAGIISQPLLKEDLYLVGTRDCPGQSVDLTAVAEMNLFLPRDYSAVRARVTEAFTLRRLSAKIIGEIESITTLTAAIASGMGVTVLPESAARSLCSAANGWMARISTPSMSLSLSLNMSARGSLSPQAQAVKEILMSLVSRPSLENRELQLVS	MRARLPLNALRAFEASARYLNFTKAGLELHVSQAAVSQQVRTLEQMLGVALFTRVPRGLQLTDEGMHLLPSITEALQMMSSAMDKFHEGKIKEVLTIAVVGTFAIGWLLPRITAFLNENPWIDIRILTHNNVVNLAAEGIDASIRFGTGGWINTENILLFQAPHTVLCSPETSKKLYIPSDLKKVCLLRSYRKEEWNNWFKAAGIDPWTITGPIFDSTRLMIDAVKLGDYAALVPYHMFQKELNERSVAKPFEIYATLGGYWLTLQKSRVNHNSEALNVFKEWIIEHSREFVLKS	106.78	gnl|BL_ORD_ID|1951|hsp_num:0	2072		
BGC0000446.1|Tilivalline_3 # 1405 # 2379 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.561	BGC0000446.1|Tilivalline_3 	1405	2379	+	Loose	550	44.669	NmcR	35.85	3003665	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam	antibiotic inactivation	NmcA beta-lactamase	ATGTCTGATAGCCCGGAGGAAAGGGTGAACTTCCAGCAGCTCAAAATTATTCGTGAAGCGGCCCGTCAGGATTACAACCTGACGGAAGTCGCCAATATGCTCTATACATCGCAGTCGGGCGTTAGCCGCCATATTCGTGAACTGGAAGAAGAGCTGGGGATCGAGATTTTTATCCGCCGCGGCAAACGTCTGCTGGGGATGACCGAGCCGGGCAAAGCGTTGCTGTCGATTGCCGAGCGTATCCTCAATGAAGCCAGCAACGTTCGTCGCCTGGCGGACCTGTTTACCAACGATGCCTCCGGCGTCTTAACCATCGCCACTACGCATACCCAGGCGCGCTATAGTCTGCCGCCGGTGATTAAAGCCTTCCGTGAACTCTTTTCTGATGTCCGTCTTGAACTGGTGCAGGGAACGCCGCAGGAAATTGAAACGCTGCTGCATAACGGCGGCGCGGATATTGGTATCGCCAGCGAGCGTCTGAGCAACGATCCGACGCTGGTGGCTTTTCCCTGGTTCCGCTGGCACCACAGTCTGCTGGTTCCCAAAGATCATCCTCTGACCCAGGTGACGCCGTTGACCCTTGAGGCGATTGCCCGTTGGCCGCTCATCACCTATCGCCAGGGCATAACCGGCCGTTCACGCATCGATGAAGCCTTTAACCGTAAAGGGTTGATGCCGGATATCGTATTGAGCGCACAGGACTCAGACGTCATCAAAACCTACGTTGAGCTGGGGCTGGGCGTGGGGCTGGTGGCGGAACAGTCGGGAGATGAGCGGGAGTCTGATACCTTTACGCGTCTTGATACCCGCCATCTGTTCGATGCCAATACCGTCTGGCTGGGCCTGAAGCGCGGACAGCTGCAGCGAAATTACGTCTGGCGTTTTATTGAACTCTGTAATGCAGGCCTGTCGCTGGAGGAGATTAAACGCCAGGCGATGGAGCCGGAAGAGGCGGCGATCGATTATCAAATTTAG	MSDSPEERVNFQQLKIIREAARQDYNLTEVANMLYTSQSGVSRHIRELEEELGIEIFIRRGKRLLGMTEPGKALLSIAERILNEASNVRRLADLFTNDASGVLTIATTHTQARYSLPPVIKAFRELFSDVRLELVQGTPQEIETLLHNGGADIGIASERLSNDPTLVAFPWFRWHHSLLVPKDHPLTQVTPLTLEAIARWPLITYRQGITGRSRIDEAFNRKGLMPDIVLSAQDSDVIKTYVELGLGVGLVAEQSGDERESDTFTRLDTRHLFDANTVWLGLKRGQLQRNYVWRFIELCNAGLSLEEIKRQAMEPEEAAIDYQI	MRARLPLNALRAFEASARYLNFTKAGLELHVSQAAVSQQVRTLEQMLGVALFTRVPRGLQLTDEGMHLLPSITEALQMMSSAMDKFHEGKIKEVLTIAVVGTFAIGWLLPRITAFLNENPWIDIRILTHNNVVNLAAEGIDASIRFGTGGWINTENILLFQAPHTVLCSPETSKKLYIPSDLKKVCLLRSYRKEEWNNWFKAAGIDPWTITGPIFDSTRLMIDAVKLGDYAALVPYHMFQKELNERSVAKPFEIYATLGGYWLTLQKSRVNHNSEALNVFKEWIIEHSREFVLKS	109.83	gnl|BL_ORD_ID|1951|hsp_num:0	2072		
BGC0000446.1|Tilivalline_4 # 2416 # 3327 # -1 # ID=1_4;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.598	BGC0000446.1|Tilivalline_4 	2416	3327	-	Loose	500	25.0238	cmrA	31.25	3002702	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	TTGCCCGGCGCGATTCACATCAACGCCCTCGCCCTTCACAAAAGCCTGCATCGCCGGCGTGACGGGAAGCGGTACCTTGCGGTCCGATTCATACTCCGCGCGGTTTCGCGACAGCGGCTCATGAACTTCAACCCAGCGGCTACCGTCCGGCTCGGCGGTATATTTCACCGGCTGATCGATAATCTGCACCCGCGTGCCTACCGGAACGGTATCAAACAGGTACTTGATGTCGTCATTGCGCAAGCGAATGCAGCCCTGGCTCACCCGCAGGCCAATGCCGAAATTGGCGTTGGTGCCATGAATGGCGTACAGCCTGCCGATATAAATGGCGTACAGTCCCATCGGGTTATCCGGCCCGGCCGGCACAAATGCCGGCAGACTTTCGCCCCGGCTGGCATATTCCCGGCGAGTATTGGCGGTTGGCGTCCAGGTTGGCGCCTCCTGCTTACGCTCAACGGCGGTCACCCAGTTACGCGGGGTTTCGCGCCCTGCCTGGCCAATACCAATCGGCAGAACCTCGACCGTTGTGCCTTCAGGCGGATAGTAGTAAAGGCGCATTTCAGCAACGTTGATCACAATGCCGTTGCGAACCGTGGCGGGCAGGATAAGCTGCTGCGGCACCACCAGCGTGGTGCCCGATTTCGGCAGGAACACATCGACGCCCGGGTTGGCCTCCAGCATATTGCTCAGGCCCTGGCCGTACTGAGCGGCAAAGGCCTCAAGCGGCTGGGTATTGTTCTGCGGAATCGTGATGGTCAACGGGCTGCCTACCAGACGGCTTCCTTCCGGCGGCAGCGGGTAGCTCACCGCCAGAGCGCTCTGGCTGGTGAGAAGCATAATAAAAGAACAAAGCAGTTTCACGCGCCGCACAATTTCCCTTCCTCTGTGGCGATTATCGTGAATGAATTATAG	MPGAIHINALALHKSLHRRRDGKRYLAVRFILRAVSRQRLMNFNPAATVRLGGIFHRLIDNLHPRAYRNGIKQVLDVVIAQANAALAHPQANAEIGVGAMNGVQPADINGVQSHRVIRPGRHKCRQTFAPAGIFPASIGGWRPGWRLLLTLNGGHPVTRGFAPCLANTNRQNLDRCAFRRIVVKAHFSNVDHNAVANRGGQDKLLRHHQRGARFRQEHIDARVGLQHIAQALAVLSGKGLKRLGIVLRNRDGQRAAYQTASFRRQRVAHRQSALAGEKHNKRTKQFHAPHNFPSSVAIIVNEL	MPFAIYVLGLAVFAQGTSEFMLSGLIPDMARDLGVSVPAAGLLTSAFAVGMIIGAPLMAIASMRWPRRRALLTFLITFMLVHVIGALTSSFEVLLVTRIVGALANAGFLAVALGAAMAMVPADMKGRATSVLLGGVTIACVAGVPGGAFLGEIWGWRAAFWAVVVISAPAVVAIMFATPAEPPAESTPNAKRELSSLRSRKLQLMLVLGALINGATFCSFTYMAPTLTDISGFDSRWIPLLLGLFGLGSFIGVSVGGRLADTRPFQLLAVGSAALLTGWIVFALTASHPAVTLVMLFVQGALSFAVGSTLISQVLYAADAAPTLGGSFATAAFNVGAALGPALGGLAIGMGLSYRAPLWTSAALVTLAIVIGAATLSLWRRPASVQETVPA	77.49	gnl|BL_ORD_ID|1644|hsp_num:0	1744		
BGC0000446.1|Tilivalline_5 # 3499 # 3813 # -1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.492	BGC0000446.1|Tilivalline_5 	3499	3813	-	Loose	1800	25.409	mexY	29.41	3003033	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; acridine dye; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCTCGCCGCGGGTGAGAAGGCGGTGCAAAATGTGTATGAACATCATCTTCGCCCGACGGAAAAACAGCATCATCCATGGATAGAGCGCATTACCCGTCAACTGCTAGCGGCCTGCAGGGAATGGAATACGCTACTGGAAGATCGTCCGATTGCTACGGACCCCGATCAGGTTGCCGTGACAAGTACGGTTATCTGGACCTTTATTCAGGCCAGGATCCCCGATATTGTTGATGCGCAAGAGTTTCGTCACATTCAGTCGCTTGCCGAATTATTTGAAAATCATGCTGCGTTTAAAAAACATCCCTATCGCTGA	MLAAGEKAVQNVYEHHLRPTEKQHHPWIERITRQLLAACREWNTLLEDRPIATDPDQVAVTSTVIWTFIQARIPDIVDAQEFRHIQSLAELFENHAAFKKHPYR	MARFFIDRPVFAWVISLLIVLAGVLAIRFLPVAQYPDIAPPVVNVSATYPGASAKVVEEAVTAIIEREMNGAPGLLYTKATSSTGQASLTLTFRQGVNANLAAVEVQNRLKIVESRLPESVRRDGIYVEKAADSIQLIVTLTSSSGRYDAMELGEIASSNVLQALRRVEGVGKVETWGAEYAMRIWPDPAKLTSMNLSASDLVNAVRRHNARLTVGDIGNLGVPDSAPISATVKVDDTLVTPEQFGEIPLAHPRDGGAIRLRDVARVEFGQSEYGFVSRVNQMTATGLAVKMAPGSNAVATAKRIRATLDELSRYFPEGVSYNIPYDTSAFVEISIRKVVSTLLEAMLLVFAVMYLFMQNFRATLIPTLVVPVALLGTFTVMLGLGFSINVLTMFGMVLAIGILVDDAIIVVENVERLMAEEGLSPHDATVKAMRQISGAIVGITVVLVSVFVPMAFFSGAVGNIYRQFAVTLAVSIGFSAFLALSLTPALCATLLRPIDADHHEKRGFFGWFNRAFLRLTGRYRNAVAGILARPIRWMLVYTLVIGVVALLFVRLPQAFLPEEDQGDFMIMVMQPEGTPMAETMANVGDVERYLAEHEPVAYAYAVGGFSLYGDGTSSAMIFATLKDWSERREASQHVGAIVERINQRFAGLPNRTVYAMNSPPLPDLGSTSGFDFRLQDRGGVGYEALVKARDQLLARAAEDPRLANVMFAGQGEAPQIRLDIDRRKAETLGVSMDEINTTLAVMFGSDYIGDFMHGSQVRKVVVQADRRKRLGIDDIGRLHVRNEQGEMGAAGDVRQGRLDPRPAATDPLQRLSLVQPRGPGRAGLQQREAMQAMEQLMQGTARGIRPRVVRPVLRRTPVAGAQAPALFALSVLIVFLALAALYESWSIPLAVILVVPLGVLGALLGVSLRGLPNDIYFKVGLITIIGLSAKNAILIIEVAKDHYQEGMSLLQATLEAARLRLRPIVMTSLAFGFGVVPLALSSGAGIRAQVAIGTGVLGGIVTATVLAVFLVPLFFLVVGRLFRLRKAPRTGNSPQIPTEQA	9.94	gnl|BL_ORD_ID|1687|hsp_num:0	1786		
BGC0000446.1|Tilivalline_6 # 4283 # 5188 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.542	BGC0000446.1|Tilivalline_6 	4283	5188	+	Loose	550	139.813	NmcR	32.52	3003665	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam	antibiotic inactivation	NmcA beta-lactamase	ATGGCGGATTTTCCCCCGATTGCGAGTTTACGTAGTTTTGAAGCCGTGGCTCGTCTTGGCAGCGTTACGCTGGCGGCGAAAGAACTACACGTTACGCACTCAGCTATCAGTCAGCAGATTAAAGTGCTGGAGGAGAGGGTCGGCTTAAAGCTGTTTATTCGTCACGGTCGCGGCCTGCAGATTAATGAAGAGGGACGACTCTACGCCTTGCAGGTACGCGAGGCCCTTAACCATATCGCTGACGCCACCCGACTGGTGCAGGTAAAGCCCCGCAGACAGGAGCTGACGATAGCGGTGGTACCCTCTTTTGGAGGCCACTGGCTTTTGCCTCGTCTTGAGCGGTTTCGGGCGAAATACCCTCAAATCACGCTGCGAATACAGGCAAACCTGGCGGTCACTCATCTGCAGCAGGAAGGGGCAGATTTGGCCATCCGCATGGGAAAAGGGGACTGGGAAGGCACGGAGAGTCATTATCTTTTCTCCGATGAGCTTATCGTTGTGGCTGCTCCATCTTATAACGGCGGTGAGCTACCCCGTACGCCGTCAGAGATAGCGCAGAGCAAGATTATCTTTTCCATGGAATCGTGGAAAACCTGGTGTATCAAGGCAGGGCTTGAAAGAGAGATTGTGCCCGGCGGGCTATGCATAAACGACTCAAATCTGGTGCTGGAGGCCGTCCGGCTCGGTAAAGGTGTTGCGCTGGAACGCCGATCTTTAGTCCAGGATGCTATTGCCCGGGGAGAGCTGGAACAGCTTACCCCTTTCGCCGCGCCTTATCCGTGGCCTTACTGGCTGGTCTCATCGCAAGTTGCAGAAAAGAAAAACGAAGCTGTGCTTTTTAAGGACTGGCTTAGTGAGGAGGTTGTTGCCTGGCGTCAGCAAACGGCAACGGTAGAAGAGAGATAA	MADFPPIASLRSFEAVARLGSVTLAAKELHVTHSAISQQIKVLEERVGLKLFIRHGRGLQINEEGRLYALQVREALNHIADATRLVQVKPRRQELTIAVVPSFGGHWLLPRLERFRAKYPQITLRIQANLAVTHLQQEGADLAIRMGKGDWEGTESHYLFSDELIVVAAPSYNGGELPRTPSEIAQSKIIFSMESWKTWCIKAGLEREIVPGGLCINDSNLVLEAVRLGKGVALERRSLVQDAIARGELEQLTPFAAPYPWPYWLVSSQVAEKKNEAVLFKDWLSEEVVAWRQQTATVEER	MRARLPLNALRAFEASARYLNFTKAGLELHVSQAAVSQQVRTLEQMLGVALFTRVPRGLQLTDEGMHLLPSITEALQMMSSAMDKFHEGKIKEVLTIAVVGTFAIGWLLPRITAFLNENPWIDIRILTHNNVVNLAAEGIDASIRFGTGGWINTENILLFQAPHTVLCSPETSKKLYIPSDLKKVCLLRSYRKEEWNNWFKAAGIDPWTITGPIFDSTRLMIDAVKLGDYAALVPYHMFQKELNERSVAKPFEIYATLGGYWLTLQKSRVNHNSEALNVFKEWIIEHSREFVLKS	102.03	gnl|BL_ORD_ID|1951|hsp_num:0	2072		
BGC0000446.1|Tilivalline_7 # 5613 # 6845 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=TAAAA;rbs_spacer=14bp;gc_cont=0.436	BGC0000446.1|Tilivalline_7 	5613	6845	+	Loose	500	179.874	bcr-1	38.35	3003801	protein homolog model	n/a	n/a	bicyclomycin	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGCGACCGAAAGAAGTTCAGGCATCGGCAGTCAGTACGATGTTCAGAGATGAAAGTAGAGGTTTGCTTTCCAGTAAAGTCGTTATTGTTCTCGGTTTACTTAGCGCCGTTGCTGCATTATCCACTGATATGTACTTGCCTTTATTTCCAGCTATCGCCAGCGATCTGCATACGACGCCTGACAAAGTTCAGCTTAGCATCACCGCTTTTATGGTAGGCTTAGGTATTGGGCAGCTGTTTATTGGACCATTATCCGATCATTACGGCAGACGTAAATTATTGCTGGGCGGGATGGCCCTATTAACCATCGCTTCATTAGCTGGCGCTATATCTACGAACATTCAGCTGCTCATTGTTACACGGTTCTTTCAGGGACTGGGAGGAGCGGCTGGTATCGTTCTTTCCCGAGCAATTATTTCTGATCTGTGCCCGGGGACTAAAGCCGCTCGATATTTTAATCTGGTGCTAGCGATACAGGGGATCGCCCCTGTTATTGCACCATTACTTGGAGGAGTGGCTGCATGGTTTATCTGGCCGGTAGTTTTTGTTTTTATGGCTACAATATCATTAGTTTCCACTCTGCTCAGTAGTCATTTTATTAGCGAAACCTTACCCCGTCATCAGCGATTACCTTTCAATCTGAATGAGTTTATCAGTCAGTTTATCGAGTTGCTAAGCAATAAGAAATATATTGGTTATACTCTAATTTTTTCAATCCAGTTTGGGGCGCTATTTGCTTATATATCAGCATCACCATTTATCTATCAATCGACGTTCGATTTATCCTCAGGAAAGTTCGCTGTAATATTCTCTATCAACGCCGGAGCAATGATGTTTGGTAGTATAGTCAGCGCTCGCTATGTTATGAAATTTGGTGAAGATAACCTCATAACCATGGGGGTGATAAGCACGCTGGTGATATCTATATTGCTTTGTATCGTTGACAATATTTCTCATTTCCAGTTTGAGATCGCGGCGGTACTACTGTTAATGATGATGTTTACTATGGCTTTGACATTTGGCAATGCCGCGAGTATGGCCATGGCGGCATCCTCTCACTTAAAGGGAACGGGTTCTGCTATTTTAGGGGCTTTTCAGTTTGGTATCGCTGCGATAACCCCGTCACTGCTTGGATTTGGAGACCCGTTGTCATTACTGCCTATGTCGCTGATTATCGCGGGATGTTGTTTAATTGCCATCATGGCATTGTTATTGACAGGTAAAAAAGGATAG	MRPKEVQASAVSTMFRDESRGLLSSKVVIVLGLLSAVAALSTDMYLPLFPAIASDLHTTPDKVQLSITAFMVGLGIGQLFIGPLSDHYGRRKLLLGGMALLTIASLAGAISTNIQLLIVTRFFQGLGGAAGIVLSRAIISDLCPGTKAARYFNLVLAIQGIAPVIAPLLGGVAAWFIWPVVFVFMATISLVSTLLSSHFISETLPRHQRLPFNLNEFISQFIELLSNKKYIGYTLIFSIQFGALFAYISASPFIYQSTFDLSSGKFAVIFSINAGAMMFGSIVSARYVMKFGEDNLITMGVISTLVISILLCIVDNISHFQFEIAAVLLLMMMFTMALTFGNAASMAMAASSHLKGTGSAILGAFQFGIAAITPSLLGFGDPLSLLPMSLIIAGCCLIAIMALLLTGKKG	MPASASRIQVGSGERRLLLLLSALVAFGPLSIDMYLPSLPAIAADLGASDAQVQRSISGFLVGFCVGMLFYGPLSDRFGRRPVLLAGIALYLFSSLACALADSAGQLVLLRVLQALGGGAASVLARAMVRDLYPLGEAARMLALMHMVTMLAPLAAPLLGGYLMLWAGWRALFVVLALFAGLCLLAVWRVAESHPPERRGGSLAQAFLAYGRLLGDRRALGYVLCMGLAFAGMFAYISAAPFVFIEHFGVRAERFGWFFGLNILGVMLATWCSARLVRRHGPRPLLRAGSLLACVSGLFLLGYAALGERGGLWALVPGLLCFVSVTGLLGANCIASLLALYPGQAGAASAVAVSGQFGLGCLASLAVGWLALPGVLPMALVMAVCGVGSLLALGLALHGGNR	101.99	gnl|BL_ORD_ID|2394|hsp_num:0	2303		
BGC0000446.1|Tilivalline_8 # 6850 # 9072 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=TAAA;rbs_spacer=13bp;gc_cont=0.457	BGC0000446.1|Tilivalline_8 	6850	9072	+	Loose	950	50.8322	msrE	22.56	3003109	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; tetracycline antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target protection	ABC-F ATP-binding cassette ribosomal protection protein	ATGAAAACCCATGACGCTATAAAAATCATTGGTGCAAGGCAAAATAATTTGCAAGATATTGATGTAGAGGTCCCTAAAAATAAAATAACAGTTTTTACCGGTGTTTCCGGATCGGGTAAAAGCTCTTTAGTATTCGGAACTATAGCGGCGGAATCTCAGCGACAGTTAAATGACACGTTTCCACCTTTTATTCGCCATCGCTTACCACATTATGGTAATCCTGAAGTCGATGAAATTGAAAACCTGTCGGTGGCCATTATTATTGACCAAAAACGTATTGGTGGCAACGCACGTTCGACGGTGGGCACCGCATCAGATATTTATACCCTACTACGGCTACTCTTTTCTCGTGTCGGCGAACCTTTCGTAGGTTATTCGAATGTTTTTTCATTCAATCATCCTGCGGGGATGTGTGCGACATGCGACGGGTTGGGCATTGCCAGTACTATTGATATCAACCATCTGATTGATTCAAATCTGTCGTTAAATGAAGGAGCTATTCGTTATCCTTCTTTTGCGCCAGGCTCATGGCGCTGGAAACGTTATGTTTATTCAGGACTTTTTGATGCCGATAAAAAAATCGCGGATTATTCAAAAGAGGAGCGAGAATTATTACTTTATGCGGATAATCTCACTCCTGAAGCGCCGTTAGCCGGTTGGCCTAAGAGTGCAAAGTTTGAAGGCGTCATTACGCGCTTTACGCGAAGTTATTTAAAACAAGAAACTAAAGATACTAAAACTGAGGAATTTCAGCGAGTCGTTAGTTTGCAGGTTTGCCCTTCTTGTCAGGGTATGAGGCTTAACGAGGAAATACTTTCCTGCCGGATTAGAGGGAAAAATATTGGCGAATGCGCAACGCTGCCTGTCACAGAGTTAAAGCTGTTTGTAGAAAAGCTCGATTACCCTGAAGTCAGGCCGCTGATCGAAGCATTGCTGGAAAGGTTGGATGCCATGTGTGCAGTAGGCTTGGGATATCTGGATTTGAACCGTACGACCCCTAGCTTATCGGGCGGTGAGTCCCAGCGGTTGAAAATGGTCCGACATCTGGGAAGTAGTCTGACCGGGATCGTTTATATAATTGATGAACCCAGTACCGGCCTGCATCCAGCAGATATAGTGAAATTGAATGTTTTAATTGGAAAACTACGCGACAAAGGCAATACCATTCTGATGGTGGAGCACGACCCGGACATGATAGCGATAGCCGAGCATGTTATTGATTTAGGGCCAGGAGCGGGTAAGCAAGGCGGGAATATTGTCTTTGAGGGCGACCTGTCGGCACTTAAGCAATCCCAAACCTTGACGGGTCGATATTTCTCTTCACGGGCAGAGATAAATAAGAAACCGAGATGTGCCAAGGGTTATATATCGGTAAGAAACGCCACATTGCATAACCTGCATAACTTATCGGTAGACGTGCCTTTAAGCGTTATGGTCGCTGTGACGGGAGTCGCTGGATCGGGCAAAAGTTCATTCGTTATGGGGGCCCTGGCGCCACAATGTCCGGAGGCGATCGTTATCGATCAAAAACCGATACATACCTCAATTCGATCGCATATTGCTTCCTGGTGCGGTGCATTTGATACGATCCGTTCGCTGTTTGCCGAAAAAAACCATGTGTCAGCGTCGTGGTTTAGCGCTAATGCCAAAGGGGCTTGTCCGGAATGTAATGGGCTAGGGGTAATACAAACCGATCTGGCATTTATGGATACGGTTACGTTGCCATGTGAGGCCTGCCAGGGGCAGCGCTATAACCCACAAGCGCTGAAATATCGTTATCAGGGAAAAAGTATTGCTGAGGTATTATCCCTGTCGATTAATGATGCCTGCGAATTTTTCCTTAATGAGCCACAGCTCAGGCCAATTTTTCGTAGCCTGGTCGAAGTCGGGTTGGGATATTTACGCTTGGGTGAATCGTTAAATCATCTTTCAGGCGGTGAATGCCAGCGGCTGAAGTTAGCGTCACAATTAAATCATGATAGTGACATGTATATTTTCGATGAGCCAACCACGGGTCTTCATCCCAGTGATGTAGCCTCGCTGTTGAAACTATTTAACCGACTGGTAGCGCGCGGAAACACCGTCATTATTATTGAACATAATATGGAGTTGATCGCTCAGGCTGACTGGATTATTGATATTGGACCTTATGCCGGGAAAGAAGGGGGGGATTATTGTTTAGCGGTACACCCGAATCGATGCTGGCCTGTCGCCATTCATTAA	MKTHDAIKIIGARQNNLQDIDVEVPKNKITVFTGVSGSGKSSLVFGTIAAESQRQLNDTFPPFIRHRLPHYGNPEVDEIENLSVAIIIDQKRIGGNARSTVGTASDIYTLLRLLFSRVGEPFVGYSNVFSFNHPAGMCATCDGLGIASTIDINHLIDSNLSLNEGAIRYPSFAPGSWRWKRYVYSGLFDADKKIADYSKEERELLLYADNLTPEAPLAGWPKSAKFEGVITRFTRSYLKQETKDTKTEEFQRVVSLQVCPSCQGMRLNEEILSCRIRGKNIGECATLPVTELKLFVEKLDYPEVRPLIEALLERLDAMCAVGLGYLDLNRTTPSLSGGESQRLKMVRHLGSSLTGIVYIIDEPSTGLHPADIVKLNVLIGKLRDKGNTILMVEHDPDMIAIAEHVIDLGPGAGKQGGNIVFEGDLSALKQSQTLTGRYFSSRAEINKKPRCAKGYISVRNATLHNLHNLSVDVPLSVMVAVTGVAGSGKSSFVMGALAPQCPEAIVIDQKPIHTSIRSHIASWCGAFDTIRSLFAEKNHVSASWFSANAKGACPECNGLGVIQTDLAFMDTVTLPCEACQGQRYNPQALKYRYQGKSIAEVLSLSINDACEFFLNEPQLRPIFRSLVEVGLGYLRLGESLNHLSGGECQRLKLASQLNHDSDMYIFDEPTTGLHPSDVASLLKLFNRLVARGNTVIIIEHNMELIAQADWIIDIGPYAGKEGGDYCLAVHPNRCWPVAIH	MSLIIKARNIRLDYAGRDVLDIDELEIHSYDRIGLVGDNGAGKSSLLKVLNGEIVLAEATLQRFGDFAHISQLGGIEIETVEDRAMLSRLGVSNVQNDTMSGGEETRAKIAAAFSQQVHGILADEPTSHLDLNGIDLLIGQLKAFDGALLVISHDRYFLDMVVDKIWELKDGKITEYWGGYSDYLRQKEEERQHQAVEYELMMKERERLESAVQEKRQQANRLDNKKKGEKSKNSTESAGRLGHAKMTGTKQRKLYQAAKSMEKRLAALEDIQAPEHLRSIRFRQSSALELHNKFPITADGLSLKFGSRTIFDDANFIIPLGAKVAITGSNGTGKTSLLKMISERADGLTISPKAEIGYFTQTGYKFNTHKSVLSFMQEECEYTVAEIRAVLASMGIGANDIQKNLSDLSGGEIIKLLLSKMLLGKYNILLMDEPGNYLDLKSIAALETMMKSYAGTIIFVSHDKQLVDNIADIIYEIKDHKIIKTFERDC	150.71	gnl|BL_ORD_ID|27|hsp_num:0	33		
BGC0000446.1|Tilivalline_9 # 9195 # 10712 # -1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.490	BGC0000446.1|Tilivalline_9 	9195	10712	-	Loose	900	28.8758	otr(B)	40.74	3002892	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGAAAATAAATCAGTATCATTACCTACCGGTAATGACTTTTTAGCGGGTCTAAATGATGGGCGAGAAATATGGGCTTATGGTGAAAAGGTGGACAATGTTATTACACATCCAGCGTTTCGCAATTCAGCACTGTCCATAGCTAAATTATACGACGCGCTCCATGACGAAAAGTATCAGGCTATATTAACCACGCCTTGTGATACCGGCAGCGGTGGTGTCACTCATCCGTTCTTCCGCGTTCCTCATTCTGTTGAGGATCTGATACGCGATCGCGACGCAATCGCGCAGTGGGCACGGCTTAGCTATGGCTGGTTGGGAAGAAGCCCTGATTTCAAAGCGTCGTTTCTTACGACTCTGGGCGCCAATCCCGAGGCCTACGGCGAATATACGGATAACGCCAGGCACTGGTACAAACGTTCGCAAGAGGAGCTACTTTACTGGAATCATGCCATCATTAACCCCCCTATCGACCGCAATCTCCCGCCCGACCAGATTGAAGATATCTGCATTCACGTCGAAAAAGAGTGTGATGATGGCGTAATTGTTAGCGGTGCCAAGGTGGTTGCTACCGGCTCAGCTTTGACGCATTACAATTTCATCGCGCATTACGGTTTACCTGTCAAAAAAAGAGAATTTGCCCTGGTATGCACATTACCCATGAATGCCCCAGGACTGAAGCTGGTTTGCCGCCCCTCTTACTCCTTAGCCGCCGAAAAGGTCGGCAGTCCTTTTGACTATCCACTATCCTCACGCTATGACGAGAATGACATGATCTTCATTCTGGATAAGGTGAAGATTCCCTGGGAAAACATTTTTATTTACGGCGATACCGCTAAAGCGGCCACGTTTTTACCCAGTTCTGGCTTCCTGCACCGCTCAACCTTCCACGGAGTGACGCGTCTGGCGGTAAAAATTGATTTTATTTGTGGTTTATTCATTAAAGGCGTGGAAGCCACCGGCGTAGCCGATTTCCGCGGCATACAGACGCGCGTCGGGGAAATGCTGGCCTGGCGCAACCTCTTCTGGGCCATAAGTGATGCTATGGCTAAATCGCCGAACCCCTGGCACAACGGCGCCCTCCTGCCTAACCTGGATTATGGTTTAGCCTACCGTTGGTTTATGAGTCTCGGCTATCCACGGATCAAAGAAATTATTGAACAAGATCTTGGCAGCGCGCTTATTTATATCAATTCGCATGCCAAAGATTTCGCTGCGCCGGAACTGGAACCTTATCTGAAAAAATATATGCGGGGCTCCAACGGTATGGATGCCGTTGAACGCGTCAAGCTCATGAAGCTAATCTGGGACTCCGTAGGAACAGAATTCGCCAGCAGACACGAACTCTATGAACGAAATTATACCGGTAGTCATGAAAATGTTCGTATCGAGCTGTTGCTCGCCGCACAGATGTCGGGGCAGGTACAAGAATATAAAGGTTTCGCCGAACAATGTATGATGGATTATGACCTGGATGGCTGGCTGGATCGCGATTACCACTGGCCTTTAGACGAATAA	MENKSVSLPTGNDFLAGLNDGREIWAYGEKVDNVITHPAFRNSALSIAKLYDALHDEKYQAILTTPCDTGSGGVTHPFFRVPHSVEDLIRDRDAIAQWARLSYGWLGRSPDFKASFLTTLGANPEAYGEYTDNARHWYKRSQEELLYWNHAIINPPIDRNLPPDQIEDICIHVEKECDDGVIVSGAKVVATGSALTHYNFIAHYGLPVKKREFALVCTLPMNAPGLKLVCRPSYSLAAEKVGSPFDYPLSSRYDENDMIFILDKVKIPWENIFIYGDTAKAATFLPSSGFLHRSTFHGVTRLAVKIDFICGLFIKGVEATGVADFRGIQTRVGEMLAWRNLFWAISDAMAKSPNPWHNGALLPNLDYGLAYRWFMSLGYPRIKEIIEQDLGSALIYINSHAKDFAAPELEPYLKKYMRGSNGMDAVERVKLMKLIWDSVGTEFASRHELYERNYTGSHENVRIELLLAAQMSGQVQEYKGFAEQCMMDYDLDGWLDRDYHWPLDE	MSSANPGPAGTADQAGGAFTHRQILTAMSGLLLAVFLAALDQTVIATAMRTIADDLHGQTEQAWATTGYLIASVLAMPFYGKLSDIYGRKPMYLISIVVFIGGSVLCGTAGSMWELALFRAVQGLGGGGLMSLPTAVVADLAPVRERGRYFAFLQMAWVVASVAGPLAGGFFAEAGQVFGIDGWRWVFLLNVPLGLLALVTVRKALNLPHERREHRMDVLGAAALALFLVPLLIVAEQGRTWGWGSPAALALFALGAAGLAVFIPVELRRGDEAILPLGLFRRGSIALCSAVNFTIGVGIFGTVTTLPLFLQMVQGRTPTQAGLVVIPFMLGTIASQMVSGKLIASSGRFKKLAIVGLGSMAGALLAMATTGATTPMWGIVLIVLWLGVGIGLSQTVITSPMQNSAPKSQLGVANGASGLCRQIGGSTGIAVLFSVMFAVALGRLADLLHTPRYERLLTDPAITGDPANHRFLDMAESGQGAGINLDDTSLLNGIDARLMQPVTDSFAHGFHIMFLAGGVVLLAGFVMTWFLRELQEETAPEEERPAESGAGAKNGPLPASDA	89.70	gnl|BL_ORD_ID|910|hsp_num:0	870		
BGC0000446.1|Tilivalline_10 # 10751 # 12703 # -1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=ACG;rbs_spacer=15bp;gc_cont=0.494	BGC0000446.1|Tilivalline_10 	10751	12703	-	Loose	450	26.5646	tet(45)	34.07	3003196	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGATGTTATCTAAAGATTCAGCAAATCCCGACGAGCTTTCGGCTCATCTGGCCAATCTTGATAGACCCTTTGCCTGTATTTATCGCCCCCAATGCGAACCTATCAACGCAGTATTGTTTCTTGAAGGGGATATTGAGCTAAGCCAGTCCCTTTCAGAATTAGCGCTGGATCCTCCCCTGGACGCGACGGGCAAATGCTCATTTAACAAATTGATATTATTGCCATTTAATCAGCTGAAAGAAAAAGGATATGCCTGCATTGACGATGGTGAACAGACGATCGTAATGCACATTGAGCGGCAAGACTATTATCCTATAGATTCATTTATCGCAGCCATTAATGACCATGATATCAAGCCACGAAACCTGCACTTCGATCTTGATGACCAAACGTATGGCGACATTGTTGATACCGTGATTGATCAGGAAATCAGCTCCGGGGAAGGCAGCAACTTTGTGATTTCACGCAGCCTGGAGGGCGATATAATCGACTTTAGTATCCGCCACGCGCTGACGCTGTACAAACGGCTGCTGCAATCTGAATGCGGATCATACTGGACATGGATGATCTTTACCGGCAGCCGCTATTTCATGGGTAGTACGCCTGAACAGCATATCCAGGTTGATGAGCAGAACGTGGCGATGAATCCTATCAGCGGCACATTAAAATACCCCGATACCGGGAATATGGCGCACGTGCTGGATGATTTTCTGCAGGATAAAAAAGAGCGCGACGAACTATTTATGGTGGTAGATGAAGAACTCAAAATGATGAGTAGCATCTGTCAACGTGATATTCAGGTATCCGGGCCGAAGCTCAAGGCTATGTCGCACATCGCGCATACCGAATATTTTATCCATGGAAAATCAGATCGCAGTCTGAAAGAAATCATCAGGCAATCGCTATTTGCGCCAACAGTGACCGGCAGCCCAATAGAAAGCGCCTGTAAAGTTATCGCCCGGCGAGAACGCCGCGGACGCGGTTATTACAGCGGCATCGTTGCTATAACGGGTGCGCAAGAAGGTAAACGCTATCTGGACTCGGCCATCATGATCCGCACGGCCGATATTTCCGCTCAGGGACATTTTCGGCTTACGGCGGGTTCAACCATCGTCAGAAGTTCCATCGCGCAAAGTGAAGCCGGTGAAACACGCGCCAAATTACAAGGGCTAATGCATTCGTTCTTCTCTGAACCAAGCGCCGGGACGCCAAACCGGACAGGATTGTCTGCAGAACTTTGCCATCGGGCTGACCAGATACTGGCACAACGGAATGCACGCACCTCCGCCTTTTGGCTGGATAACTCGCAATTGGGCCCGCGCACTCTACTCTCTCATCATGCCATCACACTGATCGACATGGAGGACAACTTCACCGCCATGATTGCCTATCAGTTACGCAGCGCGGGTTGCGCCGTCACCCTCATTCCCTGGTATGACTGTCCGAGCAAGCTAACGCAACTCACCGATCGCGACATCCTATTCATTGGTCCCGGGCCTGGCGATCCAACCAATATACAACTCGAAAAAATACGCGTGGGCCGAAAAATTATTGCGCAACGGCTCCGGGAGCAGCGTCCGCTAATCGGAACTTGTCTGGGACATCAGTTAATTTGCGCCGAATTAGGCATTCCGATCGAGCGGCTGGTCAATAACCGTCAGGGTAGCCAACATCAGATATCCATTCAGGGGAAACCTCATACCGTTGGTTTCTATAACAGTTTCTCCGCACTACATCAGCGGCCATGCTGGTACAGCCCGGAGCATGACAAAACAGTCCAGCTGGAGCGACTTCCTTCCGGTGAAATTGTCGCATTATCGTCAGGCAACGTTGCCTCCATACAATTTCATAACGAATCATTCCTGACGCAAGACGCATTTTCTATTTATCAATGGCTGATACAGAACGCCTTAACAACAACGGCAACTCTTAGCCAACAAGATGCCGTTTAA	MMLSKDSANPDELSAHLANLDRPFACIYRPQCEPINAVLFLEGDIELSQSLSELALDPPLDATGKCSFNKLILLPFNQLKEKGYACIDDGEQTIVMHIERQDYYPIDSFIAAINDHDIKPRNLHFDLDDQTYGDIVDTVIDQEISSGEGSNFVISRSLEGDIIDFSIRHALTLYKRLLQSECGSYWTWMIFTGSRYFMGSTPEQHIQVDEQNVAMNPISGTLKYPDTGNMAHVLDDFLQDKKERDELFMVVDEELKMMSSICQRDIQVSGPKLKAMSHIAHTEYFIHGKSDRSLKEIIRQSLFAPTVTGSPIESACKVIARRERRGRGYYSGIVAITGAQEGKRYLDSAIMIRTADISAQGHFRLTAGSTIVRSSIAQSEAGETRAKLQGLMHSFFSEPSAGTPNRTGLSAELCHRADQILAQRNARTSAFWLDNSQLGPRTLLSHHAITLIDMEDNFTAMIAYQLRSAGCAVTLIPWYDCPSKLTQLTDRDILFIGPGPGDPTNIQLEKIRVGRKIIAQRLREQRPLIGTCLGHQLICAELGIPIERLVNNRQGSQHQISIQGKPHTVGFYNSFSALHQRPCWYSPEHDKTVQLERLPSGEIVALSSGNVASIQFHNESFLTQDAFSIYQWLIQNALTTTATLSQQDAV	MNTPHSHSNLRHNQILLWLCVLSFFSVLNEMVLNVSLPDIASDFNKEPASINWVNSSFILTFSIGTAVYGKLSDQLGIKKLLLFGIIVNCFGSVIGFVGHFFFPVLILARFIQGVGAAAFPALVMVVIARYIPKENRGKAFGIIGSIVTMGEGVGPSVGGVIAEYAHWSYILLLPVVTIITVPFLAKLLKQEEVIKGSFDTKGIIFMSVGIVFFIMFTTCYRVSFLVVSIICFLIFVKNIRKVSNPFINPSLGKNVSFMIGIICGGLIFGTVAGFISMVPYMMKDVYQLSTAAIGSGIIFPGAMSVIVFGYIGGLLVDKKGSLFVLTTGVAFLSISFLVAALFIETTPWLITIILIFVFGGLSFTKTVISTIVSSSLEQKEAGAGMSLLNFTSFLSEGTGIAIVGGLLSIHLLNRKLLPINAEPSTHLYSNLLLLFAGITIISWLVTIKMHKRSRGNI	141.92	gnl|BL_ORD_ID|151|hsp_num:0	17		
BGC0000446.1|Tilivalline_11 # 12730 # 13362 # -1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.504	BGC0000446.1|Tilivalline_11 	12730	13362	-	Loose	300	30.4166	Mycobacterium tuberculosis pncA mutations conferring resistance to pyrazinamide	25.71	3003394	protein variant model	W68L, D136H, C72W	n/a	pyrazinamide	antibiotic target alteration	pyrazinamide resistant pncA	ATGGAAAAGATACGGCCCTATCCATTGCCGACAGAACGTCAATTACCCAAATCAATTGCAGACTGGCGACCCAACAGTTCAAGAGCGGCGCTACTCATACATGATATGCAGCGTTATTTTCTCGATTTTTACACTGCTGACGCCTCGCCGATAGCGCAGGTCATCGACAACATCTACCGCTTGCTTAGCGTCGCCCGACGTCTGCATATTCCAGTATTTTATACTGCCCAACCCGGCGACATGACGCCACAACAGCGCGGCTTGCTGCACAGTCTATGGGGTTCAGGCATGAACGGCAGCCAGGAACATAAACAGATTGTTCCTCCGTTGACGCCTCTGGAAAATGAGTGGGTATTAACGAAGTGGCGTTACAGCGCCTTCTTTAACTCTCCTCTTCTGAGTACTTTGCACGAACTCAAATGCGATCAGCTGATCGTCTGCGGCGTTTACGCCCATATCGGTTGTTTGTGCACAGCGCAAGAGGCCTATTCCAATGATATCGAGACATTTTTTATTGCCGATGCGCTCGCCGATTTCTCCGAAGAAAAGCATCGTCTAGCGCTTGAGCTAGCTGCGGAAACCAGCTCAGTCGTGCTGTCAACCCGACAAGCTATCGACGCATTGGAACATTAA	MEKIRPYPLPTERQLPKSIADWRPNSSRAALLIHDMQRYFLDFYTADASPIAQVIDNIYRLLSVARRLHIPVFYTAQPGDMTPQQRGLLHSLWGSGMNGSQEHKQIVPPLTPLENEWVLTKWRYSAFFNSPLLSTLHELKCDQLIVCGVYAHIGCLCTAQEAYSNDIETFFIADALADFSEEKHRLALELAAETSSVVLSTRQAIDALEH	MRALIIVDVQNDFCEGGSLAVTGGAALARAISDYLAEAADYHHVVATKDFHIDPGDHFSGTPDYSSSWPPHCVSGTPGADFHPSLDTSAIEAVFYKGAYTGAYSGFEGVDENGTPLLNWLRQRGVDEVDVVGIATDHCVRQTAEDAVRNGLATRVLVDLTAGVSADTTVAALEEMRTASVELVCSS	112.90	gnl|BL_ORD_ID|1995|hsp_num:0	851		
BGC0000446.1|Tilivalline_12 # 13381 # 14166 # -1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.559	BGC0000446.1|Tilivalline_12 	13381	14166	-	Loose	500	32.7278	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid	29.23	3003393	protein variant model	I194T	n/a	isoniazid	antibiotic target alteration	isoniazid resistant inhA	ATGACTTTTGATAAAGATTATATTGCCGTTATTACCGGCGCATGCGGTGGCATTGGCGAATCCGTTGCCCACGCGCTGGCGAAAGAAGGGCTGTCACTAGCGCTTCTTGATAATAACGCCACTCAGCTGGCAACCCTTGTAGCCACACTACAAGATAACCATCCGCAGCCCATTGCAGGCTTTACTGTAGACGTTGCCGACGACCGCTGCGTAGCAGAGGCCTTTACCGCAGTCGGTCATCAACTGGGCCCGGTAGGGTATCTGGTCAACGGCGCCGGCGTACTGTGCCACGCCAGCGTGGCCGAAACACAACCTCAGGATTGGGCGAAAACATTTGCCGTCAACGCGACTGGCGTATTTAACACCAGCCGCCATGCGGCCAATCTGATGATGGCTCAGCGTAAAGGCAGCATCGTAACTATCGCCTCAAATGCAGCGCGCGTGCCGCGGGCGACGATGGCCGCCTACTGCGCTTCAAAAGCCGCTGCCCAGGCATTTACCTATGCTCTGGGGCTGGAGGTCGCTCCGTATGGGATCCGTTGTAATGTTGTCGCTCCCGGCTCAACCGATACGCCGATGCTGCGCGGCATGTGGCATAGCGAAAGTGACAAGCAAAACACGCTCAACGGTAACCCACAACAATTTCGCATTGGTATTCCACTCAACAAAGTCGCTACGGCGGAAGAAATTGCTGCCGCGGTCTGCTTTTACCTGTGCGAAGAATCAGGGCAAACCACGCTATCAACGTTATTGGTCGACGGTGGTGCCGCACTCGGCAGCTGCTAA	MTFDKDYIAVITGACGGIGESVAHALAKEGLSLALLDNNATQLATLVATLQDNHPQPIAGFTVDVADDRCVAEAFTAVGHQLGPVGYLVNGAGVLCHASVAETQPQDWAKTFAVNATGVFNTSRHAANLMMAQRKGSIVTIASNAARVPRATMAAYCASKAAAQAFTYALGLEVAPYGIRCNVVAPGSTDTPMLRGMWHSESDKQNTLNGNPQQFRIGIPLNKVATAEEIAAAVCFYLCEESGQTTLSTLLVDGGAALGSC	MTGLLDGKRILVSGIITDSSIAFHIARVAQEQGAQLVLTGFDRLRLIQRITDRLPAKAPLLELDVQNEEHLASLAGRVTEAIGAGNKLDGVVHSIGFMPQTGMGINPFFDAPYADVSKGIHISAYSYASMAKALLPIMNPGGSIVGMDFDPSRAMPAYNWMTVAKSALESVNRFVAREAGKYGVRSNLVAAGPIRTLAMSAIVGGALGEEAGAQIQLLEEGWDQRAPIGWNMKDATPVAKTVCALLSDWLPATTGDIIYADGGAHTQLL	97.03	gnl|BL_ORD_ID|2013|hsp_num:0	1574		
BGC0000446.1|Tilivalline_13 # 14156 # 15325 # -1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.508	BGC0000446.1|Tilivalline_13 	14156	15325	-	Loose	670	28.4906	Escherichia coli acrA	31.15	3004043	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; triclosan	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACATCATTTCCTGGCAATAAGTCCAACTGGCAACAGCCGTTCTGGAGCGATAAGGACATGCTTGCCCTGGTCAAAAGTGAATTAGACAATCTTCCAGAATTATTAAGTTTTGCAGAAATAAGTGAACTCAAGAAAGCATTAGCCGCCGTTTATGCAGGAAAAACAATGATATTTCAGGCCGGCGACTGCGCTGAAAGAATTTGCGAATCTGGCGCGTTACATGTACGGAAAAAATTGATCTTCCTTGAGCAAATGTCCCGCGAATTCTCAACACTGACGGGGCTGCCGATATTGACGGTAGGTAGAATTGCCGGTCAATATGCTAAACCCCGCTCGCAACAAAACGAAGTCGATGGCGACAGGGTACTTCCCGTGTGGCGCGGTGATTCAGTCAACCGGCCCGAAGCGACACCAGAAGCCAGGCGTAACGATCCGCAACGGATGCTGCTGAGCTATCGTGCTGCTGCGGAAACGCTGGCCGAAATTAAACGTTACGAACGGGAATATCCCCGCGATATTCATCACATTTGGACCAGCCATGAAGCGCTGTTGCTGGACTATGAAACCACTCAAATCCGCACTAATCCCTACGGAGAATCATACTTAGCCAGCACCCATTGGCCCTGGATAGGCATTCGTACTCTTGCGCCTGACAGCCCACATATCGCCATGCTGGCGAATATCGCCAACCCTGTTGCCTGCAAGATTGACGCCAGCGTAACGCCATCGTTCATCGCGTCACTTTGCCGACAGCTCAATCCTCAGCGTATTCCTGGGCGTCTGACTTTTATTTCGCGTTTTGGCCGTTCACACATTCATCGGTTGGGCGCGTTGATTCAGGCCGCGCAAGCAACCGAAACGCCGGTGTTATGGATGTGCGATCCAATGCATGGGAATACCGGGAAAACACGGGCGGGCAATAAACGCCGCGAGCTTAGCGACATGATGGCTGAAATCTCCGGTTTCCTGAGGCAGGTGAAATCACATAACGCCTGCGCCGCAGGACTCCATCTGGAAGCAACGCCGAACCCGGTCATCGAATGCTTCAGTGAAAATAATCACCCTGAAGAACATGAACTTAAGCAAATTCTCTGCGACCCACGCCTGAACGTAGCGCAAACGCAGATGTTATTAACTCACTGGAAAGAGGGACAACATGACTTTTGA	MTSFPGNKSNWQQPFWSDKDMLALVKSELDNLPELLSFAEISELKKALAAVYAGKTMIFQAGDCAERICESGALHVRKKLIFLEQMSREFSTLTGLPILTVGRIAGQYAKPRSQQNEVDGDRVLPVWRGDSVNRPEATPEARRNDPQRMLLSYRAAAETLAEIKRYEREYPRDIHHIWTSHEALLLDYETTQIRTNPYGESYLASTHWPWIGIRTLAPDSPHIAMLANIANPVACKIDASVTPSFIASLCRQLNPQRIPGRLTFISRFGRSHIHRLGALIQAAQATETPVLWMCDPMHGNTGKTRAGNKRRELSDMMAEISGFLRQVKSHNACAAGLHLEATPNPVIECFSENNHPEEHELKQILCDPRLNVAQTQMLLTHWKEGQHDF	MNKNRGFTPLAVVLMLSGSLALTGCDDKQAQQGGQQMPAVGVVTVKTEPLQITTELPGRTSAYRIAEVRPQVSGIILKRNFKEGSDIEAGVSLYQIDPATYQATYDSAKGDLAKAQAAANIAQLTVNRYQKLLGTQYISKQEYDQALADAQQANAAVTAAKAAVETARINLAYTKVTSPISGRIGKSNVTEGALVQNGQATALATVQQLDPIYVDVTQSSNDFLRLKQELANGTLKQENGKAKVSLITSDGIKFPQDGTLEFSDVTVDQTTGSITLRAIFPNPDHTLLPGMFVRARLEEGLNPNAILVPQQGVTRTPRGDATVLVVGADDKVETRPIVASQAIGDKWLVTEGLKAGDRVVISGLQKVRPGVQVKAQEVTADNNQQAASGAQPEQSKS	97.98	gnl|BL_ORD_ID|2384|hsp_num:0	2661		
BGC0000446.1|Tilivalline_14 # 15676 # 15978 # -1 # ID=1_14;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.406	BGC0000446.1|Tilivalline_14 	15676	15978	-	Loose	400	21.9422	IMP-51	33.33	3003659	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam; penem	antibiotic inactivation	IMP beta-lactamase	TTGCAACGATATCGCCTTTTATCAGGCAATTATTTTGCAACACAGCAGCCAGCGCTGAACATTGCTCAGCAAGTTCTCGATAGGTTATTTTTCTTTGATCGAAAATTAACGCAACCCTGTCCGGAAAACGTTGCGAAATCTCATCAAATATATCAGGGACAGCCTTTAACTGATAGACATATGCTGAATGCGTCATCACTCTCTCCTGGAGAATTAGGAACGTTCACACGCATAAAATCTTCTCTTGAAGAAGAAATTAAAGATCTAAAGAAATGCCGCCAGCTTACCGTGAGATGCCTCTAA	MQRYRLLSGNYFATQQPALNIAQQVLDRLFFFDRKLTQPCPENVAKSHQIYQGQPLTDRHMLNASSLSPGELGTFTRIKSSLEEEIKDLKKCRQLTVRCL	MKKLSVFFMFLFCSIAASGEALPDLKIEKLDEGVYVHTSFEEVNGWGVVPKHGLVVLVNTDAYLIDTPFTAKDTEKLVTWFVERGYKIKGSISSHFHSDSTGGIEWLNSQSIPTYASELTNELLKKDGKVQAKNSFSGASYWLVKKKIEIFYPGPGHTPDNVVVWLPEHRVLFGGCFVKPYGLGNLGDANLEAWPKSAKLLVSKYGKAKLVVPGHSEVGDASLLKRTLEQAVKGLNESKKLSKPSN	40.65	gnl|BL_ORD_ID|163|hsp_num:0	177		
BGC0000446.1|Tilivalline_16 # 17306 # 17536 # 1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.463	BGC0000446.1|Tilivalline_16 	17306	17536	+	Loose	600	21.557	BKC-1	38.46	3004757	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	BKC Beta-lactamase	ATGGACAACGTTGAGCAACAGCTACTCTCGATTTGGCAGGCGATTATTCATTCAGAGGCGATTAACCCGCACGAAAATTTACTAGACCAGGGTGGTAACTCATTACATTTCATAAAGTTGGCGTCAATGGTAAGCAAGACATTTAATTTGTCTGTCTCGCCGGCGGACATTTTCACTGCCGGAACTATTGCTGCGCTGGCTCAGACCATTCGGCAACGGCAAAAGCTCTAA	MDNVEQQLLSIWQAIIHSEAINPHENLLDQGGNSLHFIKLASMVSKTFNLSVSPADIFTAGTIAALAQTIRQRQKL	MTITFSRRQAIAGALLAVPAVSTLAASAGALLAVPAVSTLAASAGAATGGPLEKRLAELEGRHKGRIGVAIHNLATGARIGHRADERFLMCSTFKALLAAHILARVDRKEETLDRRIVVGKSDLVDWSPVVETRVGGEGISIAELCEAAITLSDNAAANLLLSASGGPKAVTQFLRGFGDDVTRLDRTEPTLNYRETPDDERDTTTPAAMAETLRKLIIGDVLARGSKAQLAAWLVMNKTGDTRLRAGFPVDWTTGDKTGTNGDRHGNANDVAIAWSPDRGAVVVTAFCEIPGISGDERNAVIAEIGRIAAEA	24.28	gnl|BL_ORD_ID|2605|hsp_num:0	3563		
BGC0000446.1|Tilivalline_17 # 17704 # 21972 # 1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=ACG;rbs_spacer=15bp;gc_cont=0.502	BGC0000446.1|Tilivalline_17 	17704	21972	+	Loose	1300	26.9498	vanTG	24.32	3002972	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanT	ATGTGGTGGCTGGATAATACGCTGGAGCAGCCCCAATGCTATAACGTGCCGGTGCTGCTGACCGTTAATGCGACACTGGACGCTGATATTATGCAGCGCGCTGTGGCTGAGCTGACCTTGCGCCATGAAATATTCAGAACGCGTTTTGTTTATCTTGACGGTAAATTACAACAGCGTATCGGCGCTGATGGCTATCTCTCTTTTTCCCATCGACAACCAGAGCAGACGGAAACCCCTGAATCCGTCACGGCACAACTGGCGGCTAGCCGTTTATCATTAGCTGAGGGGCCGCTGAGTATCATTAATATGCTCAGTTCAGACTCAGGTACAACCTGGTTAGCATGCTGCTTCCACCACATCATTATTGATGCCCCCTCAGTACGTATTGTCTTGCATGATTTGCTGCGAATCTATTGTGCGCTTGACGAGAAGCGCGTTCTGCCAGCGTTTAACGGCACGGGAAGCTATCAGGAATTTACTCGTTGGCAGGCCGCGTCCCTTGCGGCGGCTGAGTGCGAAGATATGCGGGTTTATTGGCGACAGGCACTGCATCCAGCTCCACCCTTGTCGGACCTCCCGGTCGATTTTCCCCGTCGTCTTCGGGAAGATACCAAAGCCGCCTATACCATGCTGGCGCTGAACGAACAGGAAGCGGACTCACTGCAGCGGCACGCGAGATCGTTGTCAATGACTCCATTTATGTATATGTCCATGTGCTGGCAATTTTTCCTCAGCCGTATGAGCGGGCAGAACGATATTACCGTTGGCGTGCCTTTTACTCTGCGGGATCGCAGCGAGTTTGCCGAAACGCCGGGATATATGATCAATACTCTGCCGGTTCGCGTGCAGGTCAATGAAGATGACACGGTCAGCACGCTGGCTGCAAAGGTACGTCAATCTTTTATTGGCGCACATTTCAATAAGCTGCTCCCTTTCAATGAAATTGTCGCACTGTCGCGTGAAAACGCGGGGCAGGACAGTCCTCTATTCAGAACACTGTTGGTTATGCCCGATACCCGGGGCGATATTTTCAACGACTTGCCTTTTAAAGTCATGCTGGATGACTATTTTAGCCAGATGGCAAAATACGATCTGACGCTGTTCTTTGAAGCGCAACCGCAGTGGAAGCTGACGCTGGAGTATAAGACGGCGTTGTATCACCCGCAGACCATTGACTACTGGTTGAAAATCTTTCGCCATTTATTAAGCGCGATGGGTGAGGACGGCGAGGTATTACTGTCATCCCTGAGGCTGTTGGATGCACCGTTAAGTCGTGAACTGGTTGTTCGATCTAGTCTTAAATCGTGCACGGAGGCCTGGCGATTTGACGCCCTGGCGGCTTTCAATCAGCATGCTATAAGCCACTCTGCGGATACTGCGTTAATTACCGCTAATGGCACACGATCGTATGGTTGGTTAGCGGAACGTTCAGGGCAGATTGCCGCTTACCTACAGCAGCAGTTAAATATCGCACCTGGCAAACGTGTTGCATTATTACTGGAAAGGAATGCCGAGGCGATTGCCACTCTGTTTGGCGTGTTAAAAACCGGCGCGGCCTACATTCCGATCGATCCGCAATACCCGCAAGAGCGAATTGGTTACATGTTGCAGGACGCCAGTGTGGATTGCATCGCTACGACGCGATCGCTGGTAGCAAAATTCCCAGTGTCTGGCTCCGTACCTCTGTTGTTAATCGATGATATTCCCCCGGAGTACCCTGGGGAATACTCTTATATCAAAAGAATGCCCGACGATGAGCTGTATATCATTTATACATCAGGTTCAACCGGGCAGCCCAAGGGAGTACGGTTATTAAATAAAACGCTCAATAACCTGATTAAGTGGCAACGAGATGTTTCTGAGTGCGATCAAGGAGATTGTACTCTGCATTTTATGTCACTTTCTTTTGATGTCTCGGTTCAGGAGATCTTCGGCACGTTAGCTGGCGGTGGGTGCTTATATATTGCCAGTGAAGAAGAACGGAGAGATCTGGATCTTCTGCAAGAGGTTATCCAGGAGCAGGGGATTAATCGTCTCTATTTTCCCTATGTTGCTTTGCAACAGTTCGCGCATTTGAGCGTATTGGCCAACAGGCAATTCCCGAGTTTAAAAGAGGTCTACTCCACCGGGGAACAGCTCGTACTCACCGCGGATATTAAACATTTTTTCAGGCAACCCGTTCGCCTGATTAATCTCTATGGTCCCTCAGAAAGTCACGTCTGTTCCGCGTATGTGCTGCCACCGGAAAGCGATAAATGGGGAGATGCAGCGTCCATTGGTTACCCTCTACCCGGATTTACGTTGTTGGTGGTGGATGAGCATTTGCAGCTGGTTCCCGCCGGTGTCGCCGGTGAACTGCTCATCGTTAGCGATTTTCTCTCTCCCGGCTATCACAATAAAAGTGAAGAAAGCGCTCGACGTTTTATCTCTGCTGAGGGCTTTGCCACACAAAGTTGCCACGCATATCGTACCGGTGATCTGGTGAGGCTGGAGCATGACGATCGGTTCAGCTATCTTGGCAGGATAGACAATCAGTTAAAAATTCGCGGTTTTAGGATCGAACCGTCTGAAGTAGAAGCGGCCATCAATGCCCTGGAAGGCGTGCAGGTTTCAGCGGTAGTTGGCAGGGCAGATACTTCAGGAAGCAAGCAGCTCGTCGCTTTTATTGCTGGCTTAATGGATGATAAAAGCAATCAAAAGGATAAGATCAAACGCGGCCTTCGCCTGGTTCTGCCGGAGTATATGGTTCCCACAGAGTTGGTCTTTCTGGATAAGCTGCCTACTACCCCTAGTGGGAAAATCGATCGTAAGGCGTTGCTTAAGGTGGATATTATCGTTGAATCATCCGCGCAGATGCCAGAACGGTCTCTGACGAAAACGCAGGAGCAGGTCAGGGCGCTATGGGAAACGCTATTTCCGGGTCGTCACATCGCACTGCACGATGATTTTTTCGCCATTGGCGGACATTCCTTGTTGGCTACGCAGCTGGTTTTTCTGCTCCGTAAGGCATTCAATTGCGATATTCCTCTACGTTTGTTATTTAATCATCCGACGTTGTTGGCTATGGCAGAGTGCATCGACGGCTATGTTGTCAGTGAAAAGGGGCCCGTCGATACCGTTGATCGTTCCTTTGTTCAGGATGGATACGAACGCATACATTGGCTGGGGGGAGAGTGTTCAACCCCTGGGCTGACGTTGCTCACCGGGGCGACAGGATTTTTAGGCATCTACCTGCTGCGTTCACTGCTATTGGCCGGGACCCAATCCGTGATTTGCCTGGTAAGAGCCAGGACAGATAAGCACGCATTGGCTCGTTTACGTGAAAATGCGATGCGCTACGGAATCGCCGATGAGATTGATTTTTCCCGGGTTGAAGTTTGTCTCGGTGATATTGGTCAGCGCGATTTAGGATTAAGCCCTGACGCGTATAGTCGGTTGGCAGAGCGAGTGGACACGGTATTCCATGCAGCCGCACAGATTAATTTTTTGCTCTCTTATTCTTCTGTTAAACAGTCAAATGTGCAGGGTACGCTAAATATTTTAGCTTTCTGCGGTTGTGGCGGACGAAAAACGCTCCACTATTTATCCACTATCGCCGTATTTTCTCCACGCTATCCTGAATCGCCTATCGTGGAACATTGTGTGCCGGGGCATCCGGAAGCACTGTCGATTGGTTATACGCAAAGTAAGTGGGTGGCTGAACGCTATGTTATACAGGCCAGAGAACAAGGACTTGATGCTAACGTATTTCGCATCGGACGTATTGGCGGAGACAGCCGAACTGGGGCCTGCCAGAGCGATGATTTTTTGTGGCGACAGATAAAAAGCTTTATCCAGATGGGATTGGCGCCCGATCCGTCTTCCCTGTCAACGGACCTGCTGCCTGTCGACTTTGTCGCTGAAGCGATAGTTGCTTTAGCGCGTTCAGAGGCTACTCGACAGGAGAACTTCCATATTTTCCATCCTCAGAGCATCCGGTTTGACCCGGTGTATCGGGCGATTCGTTCTCTGGGCTATCCGTTAGAAACGACTTCTGACGGCGAGTGGTTGCAACAACTTGAGCTGTGTGTCACCCAAGGGCGCGAGGTTGCGCTGGGGCCGGTCATTCATCTCTTTAAAGAGAATTTGTTGGATACTGGCGATAACGCCTATGGTAATCCAGAGACGACTAAGCGTATTACACAACTGGGCTTGCGCTTTCCTGAACTGTCGGAGGAGACTTTCAAACGTATGATTGTTTATTTCCAGCGGCAGAAAGAAATTGTCTAG	MWWLDNTLEQPQCYNVPVLLTVNATLDADIMQRAVAELTLRHEIFRTRFVYLDGKLQQRIGADGYLSFSHRQPEQTETPESVTAQLAASRLSLAEGPLSIINMLSSDSGTTWLACCFHHIIIDAPSVRIVLHDLLRIYCALDEKRVLPAFNGTGSYQEFTRWQAASLAAAECEDMRVYWRQALHPAPPLSDLPVDFPRRLREDTKAAYTMLALNEQEADSLQRHARSLSMTPFMYMSMCWQFFLSRMSGQNDITVGVPFTLRDRSEFAETPGYMINTLPVRVQVNEDDTVSTLAAKVRQSFIGAHFNKLLPFNEIVALSRENAGQDSPLFRTLLVMPDTRGDIFNDLPFKVMLDDYFSQMAKYDLTLFFEAQPQWKLTLEYKTALYHPQTIDYWLKIFRHLLSAMGEDGEVLLSSLRLLDAPLSRELVVRSSLKSCTEAWRFDALAAFNQHAISHSADTALITANGTRSYGWLAERSGQIAAYLQQQLNIAPGKRVALLLERNAEAIATLFGVLKTGAAYIPIDPQYPQERIGYMLQDASVDCIATTRSLVAKFPVSGSVPLLLIDDIPPEYPGEYSYIKRMPDDELYIIYTSGSTGQPKGVRLLNKTLNNLIKWQRDVSECDQGDCTLHFMSLSFDVSVQEIFGTLAGGGCLYIASEEERRDLDLLQEVIQEQGINRLYFPYVALQQFAHLSVLANRQFPSLKEVYSTGEQLVLTADIKHFFRQPVRLINLYGPSESHVCSAYVLPPESDKWGDAASIGYPLPGFTLLVVDEHLQLVPAGVAGELLIVSDFLSPGYHNKSEESARRFISAEGFATQSCHAYRTGDLVRLEHDDRFSYLGRIDNQLKIRGFRIEPSEVEAAINALEGVQVSAVVGRADTSGSKQLVAFIAGLMDDKSNQKDKIKRGLRLVLPEYMVPTELVFLDKLPTTPSGKIDRKALLKVDIIVESSAQMPERSLTKTQEQVRALWETLFPGRHIALHDDFFAIGGHSLLATQLVFLLRKAFNCDIPLRLLFNHPTLLAMAECIDGYVVSEKGPVDTVDRSFVQDGYERIHWLGGECSTPGLTLLTGATGFLGIYLLRSLLLAGTQSVICLVRARTDKHALARLRENAMRYGIADEIDFSRVEVCLGDIGQRDLGLSPDAYSRLAERVDTVFHAAAQINFLLSYSSVKQSNVQGTLNILAFCGCGGRKTLHYLSTIAVFSPRYPESPIVEHCVPGHPEALSIGYTQSKWVAERYVIQAREQGLDANVFRIGRIGGDSRTGACQSDDFLWRQIKSFIQMGLAPDPSSLSTDLLPVDFVAEAIVALARSEATRQENFHIFHPQSIRFDPVYRAIRSLGYPLETTSDGEWLQQLELCVTQGREVALGPVIHLFKENLLDTGDNAYGNPETTKRITQLGLRFPELSEETFKRMIVYFQRQKEIV	MTKNESYSGIDYFRFIAALLIVAIHTSPLSSFSETGNFIFTRIVARVAVPFFFMTSGFFLISRYTCNAEKLGAFIKKTTLIYGVAILLYIPINVYNGYFKMDNLLPNIIKDIVFDGTLYHLWYLPASIIGAAIAWYLVKKVHYRKAFLIASILYIIGLFGDSYYGIVKSVSCLNVFYNLIFQLTDYTRNGIFFAPIFFVLGGYISDSQNRLSLKRSIVGFIVCFALMFGEALTLHHFDIQKHDSMYVLLLPSVYCLFNLLLHFRGKRRTGLRTISLIIYIIHPFMIVVIRLFAKLLHLQSLLVENSLVHYIAVCFASVVLAVVITALLSSLKPKKAKHTADTDRAYLEINLNNLEHNVNTLQKAMSPKCELMAVVKAEAYGHGMYEVTTYLEQIGVSSFAVATIDEGIRLRKYGISSEILILGYTSPSRAKELCKYELTQTLIDYRYSLLLNKQGYDIKAHIKIDTGMHRLGFSTEDKDKILAAFSLKHIKVAGIFTHLCAADSLEENDVAFTNKQIGSFYKVLDWLKSSGLNIPKVHIQSSYGLLNYPELECDYIRVGVALYGVLSSTNDKTKLELDLRPVLSLKAKVVLIRKIKQGESVGYSRAFTATRDSLIAILPIGYADGFPRNLSCGNSYVLIGGRQAPIVGKICMDQLAVDVTDIPNVKTGSIATLIGKDGKEEITAPMVAESAESITNELLSRMGHRLNIIRRA	199.72	gnl|BL_ORD_ID|1468|hsp_num:0	1561		
BGC0000446.1|Tilivalline_18 # 22048 # 22401 # 1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=TAAA;rbs_spacer=15bp;gc_cont=0.390	BGC0000446.1|Tilivalline_18 	22048	22401	+	Loose	520	30.0314	OXA-287	38.64	3001742	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGGAGAAGTCATCGGATAAGCTGGCATCCCTTTTCTCTGTTAATGGACGTTTGTCGTTGCCTTTCCGTCGCAATAGAGAGGTGATTGTTGGCCGTGAAAATATTCGCTTACACTATGCTAATGGCTTTGGCGTTGCGCCCTTACGCTTTACCTCTATAGAGGATGAACGATTCCACTATACGAATAATCCCGATGTCGTCATTGTTGAATATAAACTACATGGGAATACTCTGCCAGATGGGAAACAGTTCTCTTTGTTATATGTTAATGTGATTGAAATAAATGATGGCAAGATAACTGAATTAATAGATTATGAGGATGTTTTGAACAGAGAATATATCTTTCAGGATTAG	MEKSSDKLASLFSVNGRLSLPFRRNREVIVGRENIRLHYANGFGVAPLRFTSIEDERFHYTNNPDVVIVEYKLHGNTLPDGKQFSLLYVNVIEINDGKITELIDYEDVLNREYIFQD	MSKKLKCLALFTAVFFAIPMTACQSFSQQKQQFSTQKNEQQQISSLFQSAQTSGVLMIYDGKKIQSYGNDLDRAEQRYIPASTFKMLNALIGIQHHKTTPDEVFKWDGKKRAFSSWEKDLTLAEAMQASAVPVYQELARRIGLELMTREVKRVGYGNKNIGTQVDNFWLVGPLKITPIEEVRFAYALAKQKLPFDQPTQQQVKAMLLVDQIQGTKIYAKSGWGMDVSPQVGWWTGWIEQPNGKITAFSLNMQMSQPEHADARKVIVYQALQELGLLAH	42.09	gnl|BL_ORD_ID|1971|hsp_num:0	3451		
BGC0000446.1|Tilivalline_19 # 22415 # 22525 # 1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.351	BGC0000446.1|Tilivalline_19 	22415	22525	+	Loose	1000	21.557	mecD	27.59	3004185	protein homolog model	n/a	n/a	penam	antibiotic target replacement	methicillin resistant PBP2	ATGTTATTAATGGGGGCGAAGGTTATGATAACTTTTCATTCCTTGAAGGGTTATGGTAAAATGGTAAGCTTAACTTATTGTATACGGCATCAGGAGAATGTATGGAAATGA	MLLMGAKVMITFHSLKGYGKMVSLTYCIRHQENVWK	MKNIKVKILIVCSLCLISFFLYNLLKENEIDKIFSSIENRNVDEINENITFLSRNTFSKKQRYDRMNHIDNSLGIKKVNITDIKLLEEIVDTRKYSANMHYDSKFGKFTKKGYFEFEKNGESKRWELNWTPEVIIPGLTATNEVRVEELKSSRGEIVDRNGIPLAIDGEHYQVGIDPKNYNKKDSKQIAKLLNINESTLKNKLKQSWVKDGVFVPIKSYVELSDEIKNKIPEYGLSVNKIKGRTYPLKEASAHLLGYIGEINADELNDPKFKGYDSHSIVGKTGIEYMYDKELQNRDGLIVYITDDDGLTDSKEILVHKKPKNGKKIVLSIDSRVQNSIYNHLKDDNGSGTAMNPKTGELLALVSYPSFNPYDFMFGISNKKYQALLNDKKAPLLNKFQELTSPGSTQKLLTSIIGLNNGVINESKSYEINGKGWRKDGSWGGYKVTRFEVVNGRIDLEKAIAHSDNIFFARTTLEMGGKKFVRGMKDLGVGEETPSDYPVRTGQIANKINLERNLNNDILLADSGYGQGEILVNPIHILSIYSSLVNEGNMMAPKLNMEHKSKVWKKHITSQKNIDILTSSMRKVVTGTHKLDTERNYANFAGKTGTAELKMTQNEGLGTQIGWFVGYDQQNPNMMLAINVKNVEDKGMSSYNAQKFAQVMDDLYEHGARTYEPDSE	5.31	gnl|BL_ORD_ID|2484|hsp_num:0	2828		
BGC0000446.1|Tilivalline_20 # 22516 # 23013 # 1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=ACG;rbs_spacer=15bp;gc_cont=0.434	BGC0000446.1|Tilivalline_20 	22516	23013	+	Loose	280	41.2022	emrR	25.93	3000516	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGAAATGAATAAAAAAGTGGCTAGTGGTTCCGAGCGCGAAATATCATTGAATCGTCAATTTGAAGATGCTTTAGGGAATTTGCAATGCGTACTTGTTGCACGTCGATCGTTGATTAATCCTGATGGTATTAACTGGCCGCAATACGATACGTTGTATATTTTACGTCAGTTCCAGCCGATGACTCCAAGCGCAATTGGTGAAAAGCTCGGATTTGCGCGTAGTAAAATGTCCAAGATCCTGCGGATGTTGAAAGATAAGCACTTTGTTGAGCAGGAGTCGGCAGAAAGCGACAAGCGAGAAATGCTGACGAGGATTACGGAAAAGGGTATTGAATTCCTGAATTCTGCAGAGTCCAGCAGGCGCATAATGGCTGAGCAGGTGGCATCCTGTATGTCGCAGGGAGAGATTGCTATTTTCGCTGAGCTTTGTACAAGGGCTGCCAATATATTACACGAGAATATTAAAGGTAAACTCGAAGATACCAGTGAAAATTAA	MEMNKKVASGSEREISLNRQFEDALGNLQCVLVARRSLINPDGINWPQYDTLYILRQFQPMTPSAIGEKLGFARSKMSKILRMLKDKHFVEQESAESDKREMLTRITEKGIEFLNSAESSRRIMAEQVASCMSQGEIAIFAELCTRAANILHENIKGKLEDTSEN	MDSSFTPIEQMLKFRASRHEDFPYQEILLTRLCMHMQSKLLENRNKMLKAQGINETLFMALITLESQENHSIQPSELSCALGSSRTNATRIADELEKRGWIERRESDNDRRCLHLQLTEKGHEFLREVLPPQHNCLHQLWSALSTTEKDQLEQITRKLLSRLDQMEQDGVVLEAMS	93.75	gnl|BL_ORD_ID|1253|hsp_num:0	1330		
BGC0000446.1|Tilivalline_21 # 23402 # 23656 # -1 # ID=1_21;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.447	BGC0000446.1|Tilivalline_21 	23402	23656	-	Loose	750	23.8682	tet(52)	50.0	3004587	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	TTGAGCACCTCAGATGCACCCGGTAGCGGGATCATTTCTCTGTACGCAAGAGCTGAATCGATCATTATCAGCAGGGGCAATCATTTACTCGGCTGTCTGTTTTGCGGGGGCAATGAAGGAAGAGAACAAAATGCACCAGTTGCATACCTGCTACTTTCACATTTATTCATCGATATATTGAAAGTAAAGAAATATCTGCTACAGGTATTCGCCAAAACTCCTGTGCTCACCAGACGTAGTGCGAGAATACGCTAA	MSTSDAPGSGIISLYARAESIIISRGNHLLGCLFCGGNEGREQNAPVAYLLLSHLFIDILKVKKYLLQVFAKTPVLTRRSARIR	MSNVNKILVIGAGIAGPAACYWLRRFGFSPVLVERSASLRKGGHALDVRGVAIDLVKRMGIYQKIYNMRTQLEFGRHVDPEGNTLHEEKGERFGFREGQDVEIIRSDLVEILIDSIEGVPLQFNQTIESVKQTDAVVEVQFKDGRTEHFDLVIGADGLHSTTRRIVFDKHEYKLNDLGAYFSVFSIPNYLNLNNTEVQCEANQKLLSITSDKNRKMAEVAFSFRGQNVLNNVRDESEQRRVLRDTFQDFGWEAPRILELMSDSDDFYSDSFTQVIMKSWTKGRVALLGDAAYSASPISGQGNNLALVGAYVLAGELKQAGGNYKRAFDRYNEILRPFIEANQKLGVLVNESFLVRDEVSKEVAEERSNNIMEQVKIASNMIVLQDYANPH	21.54	gnl|BL_ORD_ID|2756|hsp_num:0	3289		
BGC0000446.1|Tilivalline_22 # 23741 # 24046 # -1 # ID=1_22;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.461	BGC0000446.1|Tilivalline_22 	23741	24046	-	Loose	1300	23.0978	vanTE	27.5	3002971	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanT	ATGTTTGACAAAAGTTTTTTCGCCGCTAAGATACGACTCCACAACGATTCCTCTGTAGTTCAGTCGGTAGAACGGCGGACTGTTAATCCGTATGTCACTGGTTCGAGTCCAGTCAGAGGAGCCAAATTCCTGTTTTCAGCTATCTATGCGAATCTTTTTCAGATATTGATTCAACAGGCTAGCATGGGAACACATCTCGGTGCATTTCTGGTTTTTTCTCCTCCGTGCCGGGAAATGCGGGCACTATCTTTGTTGCGCATAGCATGTCCCACTTCTCCCTTAACAACACGCCAATTGTCAGCCTGA	MFDKSFFAAKIRLHNDSSVVQSVERRTVNPYVTGSSPVRGAKFLFSAIYANLFQILIQQASMGTHLGAFLVFSPPCREMRALSLLRIACPTSPLTTRQLSA	MKHRANGIDLFRIFAATMVVAIHTFPFQSIAPFLDEVITLTVFRVAVPFFFMITGYFLLGRLSLNFSYNNNQRVKKYLYKIGMIYLYSILLYFPLSLLNGTISLKMNILLLLKVFIFDGTFYHLWYFPASIIGTILVTLLLRSIGFKLTVAFSTCLYLVGLGGDSWYGITNQVPLLNKLYTFIFSWSDYTRSGVFFTPVFLCLGIFAYRVSKKLTASKILNLLFYVFIIGMTFESIFLHRFTNVKHDSMYLLLPSCALILFLMLLNWQPKLKVKESADLTLLVYILHPLVIVIVHSISKYIPILKNSLLNFLLVVVCSFILAQLLLNLKRKLRVSKQKIPFERASKEISASAIHHNINEIRKIIPKNTNIMGVVKANAYGCGMVEVAYELEKIGISFFCVATIEEAIALRKSGNQGDILILGYTHPNRINDIKKYNLIQSIVSEEHGKVLNLKKIPIRCHLQVDTGMHRLGVTPNVTIIQQMYLFSNLKIEGIYSHLGSSDSLEQESIARTNTQIFLFNNILSDLEQMGISYGYTHIQSSYGILNYPELSFDFVRIGILCYGFLSDYNSPTKIPIDLQPIVKVKASLITERIVEAGEYVGYGLGAKVEKRTRIGVVSIGYADGIPRALSNAKLTLEFKGQSIKQIGNICMDMMLVDLSEVEDISLNDELIVLPNISKIADEEQTITNELLSRLGSRLGTELN	14.39	gnl|BL_ORD_ID|1234|hsp_num:0	1308		
BGC0000446.1|Tilivalline_24 # 24892 # 25212 # -1 # ID=1_24;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.551	BGC0000446.1|Tilivalline_24 	24892	25212	-	Loose	600	25.409	APH(9)-Ib	36.67	3002663	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(9)	GTGCCACGCCTGACGTTCAGCCTGGCCGATCTGACCTTTTCCGAGACGCCTGCCGGTAATAATTGTCGATGCGGAACCCAGGGCGTTCCCGGGCAGGTTAATCAGCGCAGCCACGGAGAAGGCGATAAAGTTGCCAGCAATCACGTTAGTCCCCATCCCGGCAACGAACATCTGAGTCAGCAGCTTGCCGCCGTTGAACAAAACCGATTCAATGCTGGCGGGAATACCAATGCCCATCACTTCCCAGATAATGGCGAAGTTGAACGGCTTAAAGTAGCTCTTCAGCGAAATGCGCAGCGCCGGGTTAAAGCCGATCATTAA	MPRLTFSLADLTFSETPAGNNCRCGTQGVPGQVNQRSHGEGDKVASNHVSPHPGNEHLSQQLAAVEQNRFNAGGNTNAHHFPDNGEVERLKVALQRNAQRRVKADH	MEDLPENLDQESLFQGLREFGISTTSASYAPLGFGDYHWHITGDDGQRWFATVSDLEHKEHCGHGAPAALRGLRRAMDTAVHLREQGGLPFVVAPRTTSDGASLVPLDSRYALTVFPHVSARPGEFGQKLTERERDQVLVLLAELHGQAPPKCTPTTDMVPTGLDGVHTALAEPSGTWTGGPFSEPARELLAEHEATLRGRMAEFGELVARVRGRGAPLVVTHGEPHPGNLILGEDGYVLVDWDTVGLAIPERDLSLISDDPAALARYTELTGHTPDPAALALYRLRWSLLDVAEFVEWFRGEHQRTSDTEAAWQSFAETLDHLNSEVPS	32.12	gnl|BL_ORD_ID|995|hsp_num:0	1059		
BGC0000446.1|Tilivalline_25 # 25222 # 25746 # -1 # ID=1_25;partial=00;start_type=ATG;rbs_motif=ACG;rbs_spacer=15bp;gc_cont=0.562	BGC0000446.1|Tilivalline_25 	25222	25746	-	Loose	500	23.8682	NDM-7	29.55	3002357	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam	antibiotic inactivation	NDM beta-lactamase	ATGACGCCCGATCTTGTCAAAGGCTGTTTGCACATTTCAAACCGTTTGCCGAAAAATCCTCCACTTTGCGCAAAAAGTAGCGTTTATCCGCTTATCACTCGCCTATTCAGCCTGCGCCTGACTCTCCTCTACCTGCAATTTGGTACGTGGATACTTCCACAGCCACCGCCCGCTGACCATTCGGCAGTAAAACAAAACGCCGCGCACCGCCCAGTCAAGCACCATCCCCAACCAGACGCCAATCACTCCCATACCCAGCACAATCCCCAGCGTGTAGCCCGCCACGACGCGACAGCCCCACATGCCGAGCATGGATACCCACATGGTGTAGCGCACGTCACGTGCGCCTTTAAAGGCGCACGGCAGCGTCCAGGCCATCGCCCAAATCGGCATAAAGAAGGCGTTGAGCCACAGCAGCTCTTTCACCACTACCTTGACATCCTCTTCGCTGGTATAGAACGAAGCGATCAGGCCAGCAAACGGTGCGGTTCCCCAGGCGATCAGCGTCAATACGATCGTCGATAG	MTPDLVKGCLHISNRLPKNPPLCAKSSVYPLITRLFSLRLTLLYLQFGTWILPQPPPADHSAVKQNAAHRPVKHHPQPDANHSHTQHNPQRVARHDATAPHAEHGYPHGVAHVTCAFKGARQRPGHRPNRHKEGVEPQQLFHHYLDILFAGIERSDQASKRCGSPGDQRQYDRR	MELPNIMHPVAKLSTALAAALMLSGCMPGEIRPTIGQQMETGDQRFGDLVFRQLAPNVWQHTSYLDMPGFGAVASNGLIVRDGGRVLVVDTAWTDDQTAQILNWIKQEINLPVALAVVTHAHQDKMGGMNALHAAGIATYANALSNQLAPQEGLVAAQHSLTFAANGWVEPATAPNFGPLKVFYPGPGHTSDNITVGIDGTDIAFGGCLIKDSKAKSLGNLGDADTEHYAASARAFGAAFPKASMIVMSHSAPDSRAAITHTARMADKLR	64.44	gnl|BL_ORD_ID|547|hsp_num:0	585		
BGC0000446.1|Tilivalline_26 # 25765 # 25845 # -1 # ID=1_26;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.506	BGC0000446.1|Tilivalline_26 	25765	25845	-	Loose	2070	20.0162	smeE	31.58	3003056	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; tetracycline antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	TCCTCTGACTGGACTCGAACCAGTGACATACGGATTAACAGTCCGCCGTTCTACCGACTGAACTACAGAGGAATCGTTTGA	SSDWTRTSDIRINSPPFYRLNYRGIV	MARFFIDRPIFAWVIAIIIMLAGGLALFKLPVSMYPNVAPPAVEISATYPGASAKVVEDSVTQIIEQNMKGLDGLIYFSSNSSSNGQATITLTFESGTNPDIAQVQVQNKLQLAMPLLPQEVQRQGINVAKSSSGFLNAIAFVSENGSMDANDIADYVGSNVVDRLSRVPGVGNIQVFGGKYAMRIWLDPNKLHTYGLSVPEVTAAIKAQNAQVAIGQLGGAPSVKGQQLNATINAQSRLQTPEQFRNIIVRGAQDGAELRLGDVARVELGAESYDFVTRYNGQPASGLAVTLATGANALDTAAGVDAALEDMKGFFPAGLKAEIPYDTTPFVRVSIKGVVQTLIEAIVLVFVVMYLFLQNFRATLIPTIAVPVVLLGTFGVLAMLGFSVNMLTMFAMVLAIGLLVDDAIVVVENVERIMSEEGLSPLEATRKSMGQITGALVGIGLVLSAVFVPMAFMSGSTGVIYRQFSATIVSAMALSVLVAIVLTPALCATMLKPLKKGEHHVAHRGLAGRFFNGFNRGFDRTSESYQRGVRGIIHRPWRFMGIVAALFVLMGVLFVRLPSSFLPNEDQGVLMALVQAPVGATQERTLESIAALENHFLQNEKDAVDSVFSVQGFSFAGMGQNAGMAFVKLKDWSERDADNGVMPITGRAMAALGQIKDAFIFAFPPPAIPELGTASGYTFFLKDNSGQGHEALVAARNQLLGLAAGSKKLANVRPNGQEDTPQFRIDIDAAKATSLGLSIDQINGTLAAAWGSSYIDDFVDRGRVKRVFVQADQAFRMVPEDFDLWSVKNDKGEMVPFSAFATKHWDYGSPRLERYNGVSAMEIQGEPAPGVASGDAMAEIEQLAKQLPAGFGIEWTAMSYQERQAGSQTPLLYTLSLMIVFLCLAAMYESWSVPTAVLLAAPLGILGAVLANTFKGLERDIYFQVAMLTTVGLTSKNAILIVEFAKENLEKGASLIESIMHAVRDRLRPIVMTSLAFGMGVVPLAISTGAGSGAKQAIGTGVLGGMIVGTVLGVFFVPLFFVVVQRVFKRRSTT	2.50	gnl|BL_ORD_ID|825|hsp_num:0	876		
BGC0000446.1|Tilivalline_23 # 24211 # 24573 # -1 # ID=1_23;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.565	BGC0000446.1|Tilivalline_23 	24211	24573	-	Loose	270	22.3274	MexR	30.23	3000506	protein overexpression model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; peptide antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; sulfonamide antibiotic; phenicol antibiotic; penem	antibiotic target alteration; antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGATAACCGCAGCGAGAATAATCGAGAACAGGGTCATTATCGCCAGCGACTGTCGCGCTGCCGCCCTTGCCCGCCGCCGGTCACGCTTGCCCAGACTGAAGGCTACCACCACGGTCGTACCGAGATCGATGGCGGCAAAAAAGGACATGATCACCATGTTGAAGCTATCGGCCAGGCCAACGCCCGCCATCGCTTCTTTACCGAGCCAGCTGACCAAAAAAGTACTCAGCACGCCCATCAGCAACACGCAGGCGTTTTCCAGCAAAATCGGGACCGCAAGTGGACTGATTTCACGCCAGTAGAGGACGCGATAGGTCTTGCGTTTTTTAAACCAGGACGTGCGTTCGACGGACTGGCGTAA	MDNRSENNREQGHYRQRLSRCRPCPPPVTLAQTEGYHHGRTEIDGGKKGHDHHVEAIGQANARHRFFTEPADQKSTQHAHQQHAGVFQQNRDRKWTDFTPVEDAIGLAFFKPGRAFDGLA	MNYPVNPDLMPALMAVFQHVRTRIQSELDCQRLDLTPPDVHVLKLIDEQRGLNLQDLGRQMCRDKALITRKIRELEGRNLVRRERNPSDQRSFQLFLTDEGLAIHQHAEAIMSRVHDELFAPLTPVEQATLVHLLDQCLAAQPLEDI	81.63	gnl|BL_ORD_ID|2395|hsp_num:0	1474		
